Search research articles
Contact Us
Filters
Showing results (11-20 of 28) with videos related to
Page
of 3
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
February 19, 2000
Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors
J N Parker, G Y Gillespie, C E Love, et al.
Cancer Gene Therapy
|
September 23, 2006
Engineered herpes simplex virus expressing bacterial cytosine deaminase for experimental therapy of brain tumors
M B Guffey, J N Parker, W S Luckett, et al.
Cancer Research
|
April 15, 1997
Evaluation of genetically engineered herpes simplex viruses as oncolytic agents for human malignant brain tumors
S Andreansky, L Soroceanu, E R Flotte, et al.
Gene Therapy
|
April 13, 2007
Enhanced antiglioma activity of chimeric HCMV/HSV-1 oncolytic viruses
A C Shah, J N Parker, G Y Gillespie, et al.
The Journal of Biological Chemistry
|
August 22, 2001
pH alterations "reset" Ca2+ sensitivity of brain Na+ channel 2, a degenerin/epithelial Na+ ion channel, in planar lipid bilayers
B K Berdiev, T B Mapstone, J M Markert, et al.
Gene Therapy
|
April 16, 1998
Treatment of intracranial gliomas in immunocompetent mice using herpes simplex viruses that express murine interleukins
S Andreansky, B He, J van Cott, et al.
Gene Therapy
|
May 6, 2011
Increased oncolytic efficacy for high-grade gliomas by optimal integration of ionizing radiation into the replicative cycle of HSV-1
S J Advani, J M Markert, R F Sood, et al.
Cancer Research
|
May 8, 1999
Replication-competent, nonneuroinvasive genetically engineered herpes virus is highly effective in the treatment of therapy-resistant experimental human tumors
S J Advani, S M Chung, S Y Yan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 2, 1999
Ionizing radiation improves survival in mice bearing intracranial high-grade gliomas injected with genetically modified herpes simplex virus
J D Bradley, Y Kataoka, S Advani, et al.
Gene Therapy
|
August 15, 2014
Assessment of oncolytic HSV efficacy following increased entry-receptor expression in malignant peripheral nerve sheath tumor cell lines
J D Jackson, A M McMorris, J C Roth, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 28) with videos related to
Sort By:
Page
of 3
Proceedings of the National Academy of Sciences of the United States of America
|
February 19, 2000
Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors
J N Parker, G Y Gillespie, C E Love, et al.
Cancer Gene Therapy
|
September 23, 2006
Engineered herpes simplex virus expressing bacterial cytosine deaminase for experimental therapy of brain tumors
M B Guffey, J N Parker, W S Luckett, et al.
Cancer Research
|
April 15, 1997
Evaluation of genetically engineered herpes simplex viruses as oncolytic agents for human malignant brain tumors
S Andreansky, L Soroceanu, E R Flotte, et al.
Gene Therapy
|
April 13, 2007
Enhanced antiglioma activity of chimeric HCMV/HSV-1 oncolytic viruses
A C Shah, J N Parker, G Y Gillespie, et al.
The Journal of Biological Chemistry
|
August 22, 2001
pH alterations "reset" Ca2+ sensitivity of brain Na+ channel 2, a degenerin/epithelial Na+ ion channel, in planar lipid bilayers
B K Berdiev, T B Mapstone, J M Markert, et al.
Gene Therapy
|
April 16, 1998
Treatment of intracranial gliomas in immunocompetent mice using herpes simplex viruses that express murine interleukins
S Andreansky, B He, J van Cott, et al.
Gene Therapy
|
May 6, 2011
Increased oncolytic efficacy for high-grade gliomas by optimal integration of ionizing radiation into the replicative cycle of HSV-1
S J Advani, J M Markert, R F Sood, et al.
Cancer Research
|
May 8, 1999
Replication-competent, nonneuroinvasive genetically engineered herpes virus is highly effective in the treatment of therapy-resistant experimental human tumors
S J Advani, S M Chung, S Y Yan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 2, 1999
Ionizing radiation improves survival in mice bearing intracranial high-grade gliomas injected with genetically modified herpes simplex virus
J D Bradley, Y Kataoka, S Advani, et al.
Gene Therapy
|
August 15, 2014
Assessment of oncolytic HSV efficacy following increased entry-receptor expression in malignant peripheral nerve sheath tumor cell lines
J D Jackson, A M McMorris, J C Roth, et al.
Page
of 3